In virus‐positive MCC, the viral large T antigen binds and inactivates RB, while the small T antigen interacts with various proteins, including EP400/MYCL, FBXW7, and CDC20 to promote oncogenesis (Harms et al, 2018). This evidence concerns the gene RB1 and Merkel cell skin cancer.